+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
Fibrotic Diseases Treatment Market - Global Forecast 2025-2032 - Product Thumbnail Image

Fibrotic Diseases Treatment Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 189 Pages
  • Global
From
Preeclampsia Drugs Market Report 2025 - Product Thumbnail Image

Preeclampsia Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Dermatological Drugs Market 2024-2028 - Product Thumbnail Image

Dermatological Drugs Market 2024-2028

  • Report
  • July 2024
  • 139 Pages
  • Global
From
From
Cardiotonic Agents Market - Global Strategic Business Report - Product Thumbnail Image

Cardiotonic Agents Market - Global Strategic Business Report

  • Report
  • January 2026
  • 568 Pages
  • Global
From
Hyperlipidemia Drugs - Global Strategic Business Report - Product Thumbnail Image

Hyperlipidemia Drugs - Global Strategic Business Report

  • Report
  • January 2026
  • 196 Pages
  • Global
From
Angina Pectoris Drugs - Global Strategic Business Report - Product Thumbnail Image

Angina Pectoris Drugs - Global Strategic Business Report

  • Report
  • January 2026
  • 196 Pages
  • Global
From
Dyslipidemia Drugs Market - Global Strategic Business Report - Product Thumbnail Image

Dyslipidemia Drugs Market - Global Strategic Business Report

  • Report
  • January 2026
  • 268 Pages
  • Global
From
From
Acute Coronary Syndrome - Global Strategic Business Report - Product Thumbnail Image

Acute Coronary Syndrome - Global Strategic Business Report

  • Report
  • January 2026
  • 158 Pages
  • Global
From
Atherosclerosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Atherosclerosis Therapeutics - Global Strategic Business Report

  • Report
  • January 2026
  • 181 Pages
  • Global
From
From
Loading Indicator